This is Jack. Jack is coming to Melbourne in October.
Be like Jack.

 

Be Like Jack    Be Like Jack

Come to Melbourne, Australia October 10-11th, 2018 for the
5th Biennial Why Study Mammographic Density? Conference

Keynote Speaker: Professor Jack Cuzick

Jack Cuzick is a director of Wolfson Institute of Preventive Medicine in London and a head of its Centre for Cancer Prevention. He is John Snow Professor of Epidemiology at Queen Mary, University of London. He holds a PhD in Mathematics and has previously worked at Oxford University and Columbia University, New York.  His current interests are in cancer epidemiology and clinical trials, with special interest in prevention and screening. He has been awarded CBE in Jan 2017, he is a Fellow of the Royal Society, Academy of Medical Sciences and the Royal Statistical Society.

Be like Jack.  Register now.


This is Laura. Laura knows a lot about WISDOM and is coming to Melbourne in October.
Be wise like Laura.

Be Like JackBe Like Laura

Come to Melbourne, Australia October 10-11th, 2018 for the
5th Biennial Why Study Mammographic Density? Conference

Keynote Speaker: Laura Esserman

Laura is an internationally recognized breast surgeon, breast oncology specialist, and visionary in personalized medicine, is revolutionizing breast cancer screening and treatment throughout our nation today.

As a Professor of Surgery and Radiology at the University of California, San Francisco (UCSF) and the Director of the UCSF Carol Franc Buck Breast Care Center, Dr. Esserman’s breast cancer work spans a spectrum from basic science to public policy issues and the impact of both on the delivery of clinical care. She is a provocative thought leader calling attention to and finding solutions for over-diagnosis and over-treatment of breast cancer, especially of DCIS.

Dr. Esserman led the creation of the University of California-wide Athena Breast Health Network, a learning system designed to integrate clinical care and research as it follows 150,000 women from screening through treatment and outcomes.  As part of the network, she has spearheaded the development of the WISDOM study to learn how to improve breast cancer screening by testing and comparing the safety and efficacy of a personalized screening strategy informed by each woman’s breast cancer risk and preferences against the standard of annual screening.

Dr. Esserman is a passionate and persistent advocate for her patients.  She is keenly aware that many of her patients don’t have 10 years to wait for the right treatment options. Her work is dedicated to accelerating the development of targeted, effective prevention and treatment options that can make a difference at the time when they are needed the most. Through these efforts, Dr. Esserman is helping to reshape the healthcare system, and changing it from a general population approach to a personalized and patient-centered care model.

Dr. Esserman was included as one of TIME Magazine’s 100 Most Influential People of 2016, and was the recipient of the 2016 Stanford Business School Ernest C. Arbuckle Award and the 2016 Personalized Medicine World Conference Pioneer and Luminary Award. The San Francisco Business Times honored her with the Most Influential Women in Business Awards for 2018, and she also received the 2018 Giant of Cancer Care® in Cancer Diagnostics award.

Be Like Laura. Register now.


YMD2018 is sponsored by:

Holologic logoVolpara Solutions logo